Over the course of AD progression, the link between cognitive decline and various covariates such as body mass index (21), cardiac pathologies, APOE-ε4 genotype (23–26) and sex have been explored, highlighting a higher impact of comorbidities and APOE-ε4 genotype for women on the severity of the disease symptoms. The gene discussed is APOE; the disease is Alzheimer disease.